Literature DB >> 21931011

Cutaneous manifestations of DOCK8 deficiency syndrome.

Emily Y Chu1, Alexandra F Freeman, Huie Jing, Edward W Cowen, Joie Davis, Helen C Su, Steven M Holland, Maria L Chanco Turner.   

Abstract

BACKGROUND: Mutations in the dedicator of cytokinesis 8 gene (DOCK8) cause a combined primary immunodeficiency syndrome that is characterized by elevated serum IgE levels, depressed IgM levels, eosinophilia, sinopulmonary infections, cutaneous viral infections, and lymphopenia. Many patients with DOCK8 deficiency were previously thought to have a variant of Job's syndrome. Distinguishing between DOCK8 deficiency and Job's syndrome, also referred to as autosomal dominant hyper-IgE syndrome, on the basis of clinical findings alone is challenging. The discovery of the DOCK8 mutation has made it possible to differentiate the cutaneous manifestations of these hyper-IgE syndromes. OBSERVATIONS: Twenty-one patients from 14 families with confirmed homozygous or compound heterozygous mutations in DOCK8 were evaluated. Clinical findings included dermatitis, asthma, food and environmental allergies, recurrent sinopulmonary infections, staphylococcal skin abscesses, and severe cutaneous viral infections. Malignant neoplasms, including aggressive cutaneous T-cell lymphoma, anal and vulvar squamous cell carcinomas, and diffuse large B-cell lymphoma, developed in 5 patients during adolescence and young adulthood.
CONCLUSIONS: DOCK8 deficiency and Job's syndrome share several clinical features, including elevated serum IgE levels, dermatitis, recurrent sinopulmonary infections, and cutaneous staphylococcal abscesses. However, the presence of recalcitrant, widespread cutaneous viral infections, asthma, and food and environmental allergies, as well as the absence of newborn rash and coarse facies, favors the clinical diagnosis of DOCK8 deficiency. Rates of malignancy and overall mortality in patients with DOCK8 deficiency were higher than in those with Job's syndrome, highlighting the value of distinguishing between these conditions and the importance of close monitoring for neoplasia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931011      PMCID: PMC4103903          DOI: 10.1001/archdermatol.2011.262

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  29 in total

1.  Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

2.  Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.

Authors:  T C Bittner; U Pannicke; E D Renner; G Notheis; F Hoffmann; B H Belohradsky; U Wintergerst; M Hauser; B Klein; K Schwarz; I Schmid; M H Albert
Journal:  Klin Padiatr       Date:  2010-11-05       Impact factor: 1.349

Review 3.  Dedicator of cytokinesis 8 (DOCK8) deficiency.

Authors:  Helen C Su
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-12

Review 4.  Hematopoietic stem cell transplantation for chronic granulomatous disease.

Authors:  Reinhard A Seger
Journal:  Immunol Allergy Clin North Am       Date:  2010-05       Impact factor: 3.479

5.  Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Authors:  Kaan Boztug; Manfred Schmidt; Adrian Schwarzer; Pinaki P Banerjee; Inés Avedillo Díez; Ricardo A Dewey; Marie Böhm; Ali Nowrouzi; Claudia R Ball; Hanno Glimm; Sonja Naundorf; Klaus Kühlcke; Rainer Blasczyk; Irina Kondratenko; László Maródi; Jordan S Orange; Christof von Kalle; Christoph Klein
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

6.  Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.

Authors:  Karin R Engelhardt; Sean McGhee; Sabine Winkler; Atfa Sassi; Cristina Woellner; Gabriela Lopez-Herrera; Andrew Chen; Hong Sook Kim; Maria Garcia Lloret; Ilka Schulze; Stephan Ehl; Jens Thiel; Dietmar Pfeifer; Hendrik Veelken; Tim Niehues; Kathrin Siepermann; Sebastian Weinspach; Ismail Reisli; Sevgi Keles; Ferah Genel; Necil Kutukculer; Necil Kutuculer; Yildiz Camcioğlu; Ayper Somer; Elif Karakoc-Aydiner; Isil Barlan; Andrew Gennery; Ayse Metin; Aydan Degerliyurt; Maria C Pietrogrande; Mehdi Yeganeh; Zeina Baz; Salem Al-Tamemi; Christoph Klein; Jennifer M Puck; Steven M Holland; Edward R B McCabe; Bodo Grimbacher; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

7.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

8.  Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma.

Authors:  Pensri Saelee; Sopit Wongkham; Anucha Puapairoj; Narong Khuntikeo; Songsak Petmitr; Sunanta Chariyalertsak; Wutthi Sumethchotimaytha; Anant Karalak
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jul-Sep

9.  Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.

Authors:  Wilhelm Friedrich; Catharina Schütz; Ansgar Schulz; Ulrike Benninghoff; Manfred Hönig
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 10.  Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more
  41 in total

1.  The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.

Authors:  Karin R Engelhardt; Michael E Gertz; Sevgi Keles; Alejandro A Schäffer; Elena C Sigmund; Cristina Glocker; Shiva Saghafi; Zahra Pourpak; Ruben Ceja; Atfa Sassi; Laura E Graham; Michel J Massaad; Fethi Mellouli; Imen Ben-Mustapha; Monia Khemiri; Sara Sebnem Kilic; Amos Etzioni; Alexandra F Freeman; Jens Thiel; Ilka Schulze; Waleed Al-Herz; Ayse Metin; Özden Sanal; Ilhan Tezcan; Mehdi Yeganeh; Tim Niehues; Gregor Dueckers; Sebastian Weinspach; Turkan Patiroglu; Ekrem Unal; Majed Dasouki; Mustafa Yilmaz; Ferah Genel; Caner Aytekin; Necil Kutukculer; Ayper Somer; Mehmet Kilic; Ismail Reisli; Yildiz Camcioglu; Andrew R Gennery; Andrew J Cant; Alison Jones; Bobby H Gaspar; Peter D Arkwright; Maria C Pietrogrande; Zeina Baz; Salem Al-Tamemi; Vassilios Lougaris; Gerard Lefranc; Andre Megarbane; Jeannette Boutros; Nermeen Galal; Mohamed Bejaoui; Mohamed-Ridha Barbouche; Raif S Geha; Talal A Chatila; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2015-02-25       Impact factor: 10.793

2.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

Review 3.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Additional diverse findings expand the clinical presentation of DOCK8 deficiency.

Authors:  Ozden Sanal; Huie Jing; Tuba Ozgur; Deniz Ayvaz; Dara M Strauss-Albee; Sibel Ersoy-Evans; Ilhan Tezcan; Gulten Turkkani; Helen F Matthews; Goknur Haliloglu; Aysel Yuce; Bilgehan Yalcin; Ozay Gokoz; Kader K Oguz; Helen C Su
Journal:  J Clin Immunol       Date:  2012-04-04       Impact factor: 8.317

5.  Genetic Predictors of Susceptibility to Dermatophytoses.

Authors:  Susan M Abdel-Rahman
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

Review 6.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

7.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

Review 8.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

9.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

Review 10.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.